COVID-19 emergency relief prioritised dynamic oxygen allocation, faster testing and bed access, and wider essential medicine supply.

In a COVID-19 public health emergency, the Court emphasised that scarce medical oxygen must be treated as an immediate life-saving necessity and allocated through daily review to match actual medical demand; diversion from industrial use to medical use was to be implemented without delay. It also required urgent administrative action on hospital beds, PSA oxygen plants, testing approvals, customs clearance for medical imports, and controls against hoarding and overpricing of essential medicines. On drugs and vaccines, it recognised voluntary licensing and increased production as preferred measures, but indicated that compulsory licensing, special compulsory licensing, or governmental use under the Patents Act could be pursued if voluntary steps proved inadequate.

---

---

Issues: (i) Whether the allocation and supply of medical oxygen to hospitals in the National Capital Territory required immediate intervention and dynamic review; (ii) whether additional COVID beds, testing infrastructure, clearance processes, and essential medicines required urgent administrative directions; (iii) whether the availability and production of life-saving drugs and vaccines justified invocation of the powers under the Patents Act, 1970.

Issue (i): Whether the allocation and supply of medical oxygen to hospitals in the National Capital Territory required immediate intervention and dynamic review.

Analysis: The record disclosed an acute and emergent shortage of medical oxygen, with hospitals facing imminent exhaustion of supply and serious risk to patient lives. The Central Government had already taken a decision to divert oxygen from industrial use to medical use, but implementation was delayed. The Court treated oxygen as an immediate life-saving necessity and emphasised that allocation had to respond to changing conditions and actual medical demand. It also called for reconsideration of the use of oxygen by steel and petro-chemical industries, and directed a day-to-day review of oxygen allocation to ensure efficient utilisation.

Conclusion: The Central Government was directed to implement the diversion of oxygen for medical use forthwith and to review oxygen allocation dynamically on a daily basis.

Issue (ii): Whether additional COVID beds, testing infrastructure, clearance processes, and essential medicines required urgent administrative directions.

Analysis: The materials placed before the Court showed constraints in bed availability, the need for faster operationalisation of PSA oxygen plants, delay in RT-PCR laboratory approvals, customs clearance bottlenecks for imported medical equipment, and shortages or black-marketing of critical medicines. The Court required the Central Government and concerned agencies to increase and rationalise hospital bed allocation, expedite PSA plant installation, prioritise customs clearance of medical imports, give priority to ICMR approvals, simplify the online reporting process for testing agencies, and curb hoarding and overpricing of essential drugs through strict regulatory action.

Conclusion: Administrative authorities were directed to urgently act on bed allocation, testing, logistics, and drug supply to address the COVID emergency.

Issue (iii): Whether the availability and production of life-saving drugs and vaccines justified invocation of the powers under the Patents Act, 1970.

Analysis: The Court noted shortages of several essential COVID-related drugs and observed that the public interest and urgency of the pandemic could justify recourse to statutory mechanisms for increasing supply. It referred to compulsory licensing, special compulsory licensing, and governmental use of inventions as statutory tools for enabling wider access. While recognising the interests of patent holders and licensees, the Court held that the preferred course was to encourage existing manufacturers to ramp up production and to grant voluntary licences, but that compulsory powers should be invoked without hesitation if voluntary measures failed. It also directed the Government to take steps to reduce vaccine wastage and maximise utilisation of available doses.

Conclusion: The Central Government was directed to take immediate steps to expand production and availability of essential drugs and to consider statutory powers under the Patents Act, 1970 if voluntary measures proved inadequate.

Final Conclusion: The order granted wide-ranging interim reliefs and administrative directions to address the COVID-19 crisis, especially on oxygen, beds, medicines, testing, and vaccine utilisation, while leaving the proceedings pending for further compliance and monitoring.

Ratio Decidendi: In a public health emergency, the State and its instrumentalities must prioritise preservation of life by dynamically reallocating scarce medical resources and may resort to statutory mechanisms that promote access to essential medicines when voluntary measures are insufficient.

---